Filter
1144
Filtered Results: 1144
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
110
New Publications
283
Language
Document type
No document type
517
Studies & Reports
241
Guidelines
197
Manuals
80
Strategic & Response Plan
60
Fact sheets
20
Training Material
14
Situation Updates
8
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
53
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
28
Nigeria
25
Ghana
18
South Africa
18
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Rwanda
12
Africa
12
Tanzania
12
Eastern Europe
12
Zambia
12
Latin America and the Carribbean
11
South–East Asia Region
10
Namibia
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
China
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Vietnam
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
382
Clinical Guidelines
107
Public Health
68
Key Resources
59
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
8
Toolboxes
AMR
137
Pharmacy
133
COVID-19
81
TB
57
Mental Health
55
HIV
53
Rapid Response
48
NTDs
33
Planetary Health
27
Caregiver
26
Global Health Education
25
NCDs
22
Conflict
22
Health Financing Toolbox
20
Specific Hazards
12
Ebola & Marburg
10
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO ...
Setting WHO directions
Report of a regional workshop, New Delhi, India, 29–30 September 2014
To reduce the burden of cardiovascular disease and its subsequent problems, the WHO Regional Office for South-East Asia organized a regional workshop on sodium intake and iodized salt for Member States in the South-East Asi...
To reduce the burden of cardiovascular disease and its subsequent problems, the WHO Regional Office for South-East Asia organized a regional workshop on sodium intake and iodized salt for Member States in the South-East Asi...
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Guidance on Implending Publi-Private Mix Approaches
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
Evaluating the Return on Investment of Scaling Up Treatment for Depression, Anxiety, and Psychosis
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl...
Guideline
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
WHO Vaccine Management Handbook
